Cargando…
Haematopoietic Stem Cell Transplant for Norovirus-Induced Intestinal Failure in X-linked Agammaglobulinemia
Since the first clinical description in 1952, immunoglobulin replacement therapy remains the mainstay of treatment of patients with X-linked agammaglobulinemia (XLA). However, this therapy only replaces IgG isotype and does not compensate for the loss of Bruton tyrosine kinase in non-B-lymphocytes....
Autores principales: | Shillitoe, Ben M. J., Ponsford, Mark, Slatter, Mary A., Evans, Jennifer, Struik, Siske, Cosgrove, Mike, Doull, Iolo, Jolles, Stephen, Gennery, Andrew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221090/ https://www.ncbi.nlm.nih.gov/pubmed/34164761 http://dx.doi.org/10.1007/s10875-021-01088-2 |
Ejemplares similares
-
Haematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
por: Slatter, M. A., et al.
Publicado: (2023) -
Respiratory Health and Related Quality of Life in Patients with Congenital Agammaglobulinemia in the Northern Region of the UK
por: Bryan, Branwen A., et al.
Publicado: (2016) -
Astrovirus Encephalitis in Boy with X-linked Agammaglobulinemia
por: Quan, Phenix-Lan, et al.
Publicado: (2010) -
X-linked Agammaglobulinemia Presenting with Multiviral Pneumonia
por: Arroyo-Martinez, Yadis M, et al.
Publicado: (2020) -
Autism in a Child With X-linked Agammaglobulinemia
por: Bied, Adam, et al.
Publicado: (2022)